140 related articles for article (PubMed ID: 10931631)
1. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model.
Gu X; Han YM; Titus JL; Amin Z; Berry JM; Kong H; Rickers C; Urness M; Bass JL
Catheter Cardiovasc Interv; 2000 Aug; 50(4):502-9. PubMed ID: 10931631
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: preliminary results with the perventricular technique.
Amin Z; Danford DA; Lof J; Duncan KF; Froemming S
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):234-41. PubMed ID: 14752435
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter ventricular septal defect closure with a new nanoplatinum-coated nitinol device in a Swine model.
Lertsapcharoen P; Srimahachota S; Charoonrut P
J Invasive Cardiol; 2013 Oct; 25(10):525-8. PubMed ID: 24088427
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.
Thanopoulos BD; Tsaousis GS; Konstadopoulou GN; Zarayelyan AG
J Am Coll Cardiol; 1999 Apr; 33(5):1395-9. PubMed ID: 10193744
[TBL] [Abstract][Full Text] [Related]
5. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model.
Sharafuddin MJ; Gu X; Titus JL; Urness M; Cervera-Ceballos JJ; Amplatz K
Circulation; 1997 Apr; 95(8):2162-8. PubMed ID: 9133527
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
Holzer R; de Giovanni J; Walsh KP; Tometzki A; Goh T; Hakim F; Zabal C; de Lezo JS; Cao QL; Hijazi ZM
Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
[TBL] [Abstract][Full Text] [Related]
7. Failure of the GORE HELEX atrial septal defect occluder to treat membranous VSDs in swine.
Hagler DJ; Latson LA; Goble J; Mathewson JW; Cutright W
Catheter Cardiovasc Interv; 2010 Nov; 76(6):874-7. PubMed ID: 20506100
[TBL] [Abstract][Full Text] [Related]
8. Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register.
Sideris EB; Walsh KP; Haddad JL; Chen CR; Ren SG; Kulkarni H
Heart; 1997 Mar; 77(3):276-9. PubMed ID: 9093050
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device.
Bass JL; Gruenstein D
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1153-60. PubMed ID: 22162409
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of congenital muscular ventricular septal defect.
Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
[TBL] [Abstract][Full Text] [Related]
13. Self-expanding nanoplatinum-coated nitinol devices for atrial septal defect and patent ductus arteriosus closure: a swine model.
Lertsapcharoen P; Khongphatthanayothin A; La-orkhun V; Supachokchaiwattana P; Charoonrut P
Indian Heart J; 2006; 58(4):315-20. PubMed ID: 19039147
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations.
Hijazi ZM; Hakim F; Al-Fadley F; Abdelhamid J; Cao QL
Catheter Cardiovasc Interv; 2000 Feb; 49(2):167-72. PubMed ID: 10642766
[TBL] [Abstract][Full Text] [Related]
15. [Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: a short-term evaluation].
Hu HB; Jiang SL; Xu ZY; Liu YL; Lü XZ; Zhu ZH; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1592-6. PubMed ID: 15569451
[TBL] [Abstract][Full Text] [Related]
16. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: A systematic review and meta-analysis.
Saurav A; Kaushik M; Mahesh Alla V; White MD; Satpathy R; Lanspa T; Mooss AN; DelCore MG
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1048-56. PubMed ID: 26257085
[TBL] [Abstract][Full Text] [Related]
17. Technology Insight: transcatheter closure of ventricular septal defects.
Moodie DS
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
[TBL] [Abstract][Full Text] [Related]
18. [Interventional approach to the treatment of aneurysms of the perimembranous ventricular septal defects].
Liu HM; Hua YM; Wang YB; Shi XQ; Zhu Q; Zhou TF
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):611-5. PubMed ID: 17083793
[TBL] [Abstract][Full Text] [Related]
19. Robotically assisted perventricular closure of perimembranous ventricular septal defects: preliminary results in Yucatan pigs.
Amin Z; Woo R; Danford DA; Froemming SE; Reddy VM; Lof J; Overman D
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):427-32. PubMed ID: 16434274
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children.
Thanopoulos BD; Tsaousis GS; Karanasios E; Eleftherakis NG; Paphitis C
Heart; 2003 Aug; 89(8):918-22. PubMed ID: 12860872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
